Yantai Zhenghai Biotechnology Co., Ltd. (SHE:300653)
20.48
-0.05 (-0.24%)
Feb 13, 2026, 3:04 PM CST
SHE:300653 Revenue
Yantai Zhenghai Biotechnology had revenue of 87.88M CNY in the quarter ending September 30, 2025, a decrease of -5.84%. This brings the company's revenue in the last twelve months to 347.60M, down -9.30% year-over-year. In the year 2024, Yantai Zhenghai Biotechnology had annual revenue of 363.23M, down -12.19%.
Revenue (ttm)
347.60M
Revenue Growth
-9.30%
P/S Ratio
10.47
Revenue / Employee
926.92K
Employees
400
Market Cap
3.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 363.23M | -50.43M | -12.19% |
| Dec 31, 2023 | 413.65M | -19.57M | -4.52% |
| Jan 1, 2023 | 433.22M | 33.05M | 8.26% |
| Dec 31, 2021 | 400.18M | 106.89M | 36.45% |
| Dec 31, 2020 | 293.28M | 13.47M | 4.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.69B |
| Qingdao Vland Biotech INC. | 1.39B |
| Beijing Kawin Technology Share-Holding | 1.15B |
| Guangdong VTR Bio-Tech | 830.87M |
| Boji Medical Technology | 770.19M |
| Cabio Biotech (Wuhan) | 596.47M |
| Shanghai Model Organisms Center | 419.09M |
| Shanghai Shen Lian Biomedical | 292.81M |